SLU-PP-332 10 MG
SLU-PP-332 10 MG
SLU-PP-332 is an experimental, non-peptide compound being studied for its ability to mimic some of the metabolic effects of exercise. It is sometimes called an exercise mimetic.
Unlike growth hormone peptides or GLP-1 medications, SLU-PP-332 works by activating proteins involved in energy metabolism.
What is SLU-PP-332?
|
Category |
Details |
|---|---|
|
Compound type |
Synthetic small molecule, not a peptide |
|
Classification |
ERR agonist |
|
Primary research |
Exercise endurance and metabolism |
|
Mechanism |
Activates estrogen-related receptors ERRα, ERRβ, and ERRγ |
|
Main research interests |
Fat oxidation, mitochondrial function, endurance |
|
FDA approved |
No |
|
Human clinical evidence |
No established clinical efficacy or safe dosing |
Despite their names, estrogen-related receptors are not the same as conventional estrogen receptors. They regulate genes involved in cellular energy production.
What is it being studied for?
1. Fat metabolism and weight management
Researchers are investigating whether SLU-PP-332 can increase the body's capacity to oxidize fatty acids for energy. Animal studies have reported favorable changes in metabolic function.
2. Exercise endurance
In mouse studies, SLU-PP-332 increased endurance-related performance and promoted changes in skeletal muscle associated with aerobic exercise.
3. Mitochondrial function
It activates pathways involved in mitochondrial energy production, making it interesting for research on cellular metabolism and muscle endurance.
4. Metabolic health
Researchers are examining its potential relevance to obesity, insulin sensitivity, and metabolic dysfunction.
Importantly, these findings are primarily preclinical. They do not establish that SLU-PP-332 produces the same benefits in humans.
What is SLU-PP-332 commonly stacked with?
These are combinations discussed in research-compound communities, not clinically validated stacks.
|
Compound |
Reason for combining |
|---|---|
|
MOTS-c |
Investigating complementary metabolic and mitochondrial pathways |
|
SS-31 |
Mitochondrial function and cellular energy research |
|
5-Amino-1MQ |
Fat metabolism and NNMT inhibition |
|
Retatrutide |
Appetite regulation plus experimental energy-expenditure effects |
|
Tirzepatide |
Weight management through different proposed mechanisms |
|
BAM15 |
Experimental mitochondrial energy expenditure |
|
BPC-157 / TB-500 |
Combining endurance-related and tissue-repair research |